SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFY.L Regulatory News (FFY)

  • There is currently no data for FFY

Form 8.3 - FYFFES Amendment

11 Jan 2017 09:39

Per the issuer, please disregard the below Form 8.3 - FYFFES announcement released at 11:56 am GMT on 10 January 2017 as it was sent out in error.

The correct Form 8.3 IRELAND TOP 8.3 - FYFFES PLC - BARCLAYS PLC was released at 7:00 am GMT today.

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose FYFFES
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 09 January 2017
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 8,436,972 2.56% 3,420,000 1.04%
(2) Cash-settled derivatives:
1,220,000 0.37% 1,596,972 0.48%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 9,656,972 2.93% 5,016,972 1.52%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ORD Purchase 3,420,000 2.2350 EUR

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
ORD SWAP Long 1,220,000 2.2350 EUR

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 10 Jan 2017
Contact name: Hemika Mistry
Telephone number: 020 7116 3891

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170111005460/en/

Copyright Business Wire 2017

Date   Source Headline
20th Dec 20125:25 pmRNSDirector/PDMR Shareholding
7th Dec 20124:03 pmRNSTrading Statement
1st Oct 20125:25 pmRNSGrant of share options
19th Sep 20122:47 pmRNSDirector/PDMR Shareholding
3rd Sep 20127:00 amRNSHalf Yearly Report
28th Aug 20127:00 amRNSHalf Yearly Report Date
23rd Jul 20124:29 pmRNSDirector Declaration
23rd Jul 20124:19 pmRNSDirectorate Change
20th Jul 20124:35 pmRNSPrice Monitoring Extension
29th Jun 20124:04 pmRNSBlocklisting Interim Review
15th Jun 201210:05 amRNSHolding(s) in Company
8th Jun 201211:14 amRNSHolding(s) in Company
6th Jun 20127:00 amRNSHolding(s) in Company
25th May 201210:09 amRNSHolding(s) in Company
10th May 20123:28 pmRNSResult of AGM
10th May 20127:00 amRNSTrading Statement
4th Apr 20125:06 pmRNSAnnual Financial Report
6th Mar 20125:08 pmRNSDirector Declaration
6th Mar 20125:01 pmRNSDirectorate Change
2nd Mar 20129:05 amRNSHolding(s) in Company
1st Mar 20127:00 amRNSFinal Results
23rd Feb 20122:53 pmRNSHolding(s) in Company
23rd Feb 20122:15 pmRNSNotice of Results
17th Jan 201212:14 pmRNSBlocklisting Interim Review
17th Jan 201211:14 amRNSTreasury Stock
30th Dec 201112:35 pmRNSPrice Monitoring Extension
21st Dec 20113:25 pmRNSDirectorate Change
16th Dec 20115:35 pmRNSDirector/PDMR Shareholding
1st Dec 20119:42 amRNSHolding(s) in Company
29th Nov 20114:40 pmRNSSecond Price Monitoring Extn
29th Nov 20114:35 pmRNSPrice Monitoring Extension
23rd Nov 20113:18 pmRNSHolding(s) in Company
18th Nov 20113:18 pmRNSHolding(s) in Company
18th Nov 20113:12 pmRNSTransaction in Own Shares
18th Nov 20119:59 amRNSHolding(s) in Company
14th Oct 20114:26 pmRNSHolding(s) in Company
14th Oct 20119:51 amRNSHolding(s) in Company
11th Oct 20113:27 pmRNSHolding(s) in Company
11th Oct 201111:59 amRNSHolding(s) in Company
10th Oct 20113:14 pmRNSHolding(s) in Company
10th Oct 201110:01 amRNSTransaction in Own Shares
26th Sep 201110:09 amRNSHolding(s) in Company
19th Sep 201110:15 amRNSTransaction in Own Shares
5th Sep 20117:00 amRNSHalf Yearly Report
30th Aug 20119:21 amRNSNotice of Results
15th Aug 201110:31 amRNSHolding(s) in Company
5th Aug 20112:44 pmRNSHolding(s) in Company
5th Aug 20119:15 amRNSHolding(s) in Company
2nd Aug 20114:51 pmRNSHolding(s) in Company
2nd Aug 201111:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.